Issue 6, 2005

Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors

Abstract

(−)-Cannabidiol (CBD) is a major, non psychotropic constituent of cannabis. It has been shown to cause numerous physiological effects of therapeutic importance. We have reported that CBD derivatives in both enantiomeric series are of pharmaceutical interest. Here we describe the syntheses of the major CBD metabolites, (−)-7-hydroxy-CBD and (−)-CBD-7-oic acid and their dimethylheptyl (DMH) homologs, as well as of the corresponding compounds in the enantiomeric (+)-CBD series. The starting materials were the respective CBD enantiomers and their DMH homologs. The binding of these compounds to the CB1 and CB2 cannabinoid receptors are compared. Surprisingly, contrary to the compounds in the (−) series, which do not bind to the receptors, most of the derivatives in the (+) series bind to the CB1 receptor in the low nanomole range. Some of these compounds also bind weakly to the CB2 receptor.

Graphical abstract: Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors

Supplementary files

Article information

Article type
Paper
Submitted
08 Nov 2004
Accepted
25 Jan 2005
First published
16 Feb 2005

Org. Biomol. Chem., 2005,3, 1116-1123

Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors

L. O. Hanuš, S. Tchilibon, D. E. Ponde, A. Breuer, E. Fride and R. Mechoulam, Org. Biomol. Chem., 2005, 3, 1116 DOI: 10.1039/B416943C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements